A new research program in gene and cell therapy has launched within the Herman B Wells Center for Pediatric Research<~ ink.aspx?_id="92302C6E9AFF496F9C96F9952B50ABB7&_z=za"> at Indiana University School of Medicine<~ ink.aspx?_id="92302C6E9AFF496F9C96F9952B50ABB7&_z=za">. Directed by Roland Herzog, PhD<~ ink.aspx?_id="92302C6E9AFF496F9C96F9952B50ABB7&_z=za">, the Gene and Cell Therapy<~ ink.aspx?_id="92302C6E9AFF496F9C96F9952B50ABB7&_z=za"> program seeks to improve current treatments, develop corrective therapies and explore the use of new technologies to address genetic diseases.<~ ink.aspx?_id="92302C6E9AFF496F9C96F9952B50ABB7&_z=zp">
The primary focus of the research group is to examine the interaction between gene therapies and the immune system. By examining these therapies in hemophilic models, Herzog and his team have already been successful in reversing the disease and hope to address the issue of immune rejection. While the group uses hemophilia as a model, progress in their discovery has major implications for other diseases such as diabetes, asthma and cancer.<~ ink.aspx?_id="92302C6E9AFF496F9C96F9952B50ABB7&_z=zp">
New Gene and Cell Therapy program launches in pediatric research
Sara Buckallew Jul 02, 2018
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Sara Buckallew
Communications Coordinator
Sara Buckallew works in the Dean's Office of Strategic Communications. As a communications coordinator, Sara supports internal and external communication needs for the Herman B Wells Center for Pediatric Research and the Center for Diabetes and Metabolic...